Home›Search›Cancer Innovation

Cancer Innovation

John Wiley and Sons Inc · United States · Est. 1932

ISSN2770-9191eISSN2770-9183

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.921

H-Indexi

Total Worksi

246

Total Citationsi

1,139

2yr Mean Citednessi

2.68

Open Impact Factor alternative

Aims & Scope

Subject areas: Oncology; Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Drug Discovery; Pharmacology (medical); Cancer Research.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1932

FrequencySix Issues A Year

StatusActive (last: 2026)

Total Publications246

Publisher OrgWiley

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

John Wiley and Sons Inc

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2770-9191 / 2770-9183

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

255

2022

631

2023

376

2024

183

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Drug DiscoveryQ2

OncologyQ2

Pharmacology (medical)Q2

Cancer ResearchQ3

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Drug DiscoveryCancer ResearchOncologyPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesFerroptosis and cancer prognosisDiverse Scientific and Economic StudiesHuman auditory perception and evaluationEducational Robotics and EngineeringHER2/EGFR in Cancer ResearchLung Cancer Research StudiesRadiomics and Machine Learning in Medical ImagingAdvanced Breast Cancer Therapies

Frequently asked questions about Cancer Innovation

Is Cancer Innovation a predatory journal?

PubScope has no integrity flags on record for Cancer Innovation: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Innovation?

Cancer Innovation is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.68.

Is Cancer Innovation indexed in Scopus and Web of Science?

Cancer Innovation is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Cancer Innovation?